T-CELL NEOPLASM

Clinical trials for T-CELL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new T-CELL NEOPLASM trials appear

Sign up with your email to follow new studies for T-CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat T-Cell lymphoma? pacritinib trial opens

Disease control Recruiting now

This study is for people with a type of blood cancer called T-cell lymphoma that has returned or not improved after standard treatments. Researchers want to see if the drug pacritinib can shrink tumors or stop the cancer from growing. About 100 participants will take the drug and…

Matched conditions: T-CELL NEOPLASM

Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated May 17, 2026 04:01 UTC

T-CELL NEOPLASM

Get alerted when new T-CELL NEOPLASM trials appear

New hope for Tough-to-Treat T-Cell lymphoma? pacritinib trial opens